- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Talimogene laherparepvec – July 2016
Talimogene laherparepvec: 1 million PFU/mL solution for injection, 1 × 1 mL vial, Imlygic® - July 2016
Last updated
11 November 2016